Crohn's & Colitis UK
Guide
Apr 2025
For patients
Everyone with Crohn's is advised not to smoke. The charity explains that smoking raises the risk of getting Crohn's and can make it worse, can limit which medicines you are offered (some newer tablets are generally not given to smokers), and matters before surgery. It summarises the early research on vaping and passive smoking and where to get help to stop.
Topics
Living well
Jargon explained
smoking cessation
JAK inhibitor
passive smoking
Crohn's & Colitis UK
Guide
Oct 2023
For patients
Practical ways to lower the risks of medicines that suppress the immune system. You should not have live vaccines while on an immunosuppressant, but non-live vaccines such as the injected flu jab, COVID-19, Shingrix shingles and pneumococcal vaccines are safe. It explains checks for chickenpox immunity, the slightly raised risk of some cancers, especially skin cancer, and sun safety, plus food hygiene and travel precautions.
Topics
Immunosuppressants
Vaccinations and infections
Cancer risk and screening
Travel
Biologics and newer medicines
Jargon explained
immunosuppressant
live vaccine
non-live vaccine
Shingrix
pneumococcal vaccine
JAK inhibitor
anti-TNF
New England Journal of Medicine
Study
May 2023
Patients and professionals
Three trials of upadacitinib (Rinvoq), a daily tablet rather than an injection or drip. It worked better than placebo both for settling active Crohn's over 12 weeks and for keeping it settled over a year. Some side effects, such as liver changes, low white cells and a few cases of bowel perforation, were seen more on the drug, so it needs monitoring.
Topics
Medicines
Immunosuppressants
Research
Jargon explained
JAK inhibitor
small molecule
induction
maintenance
herpes zoster
endoscopic response
NICE
Guideline
Jun 2023
For professionals
NICE's appraisal recommending upadacitinib (Rinvoq), a tablet, for adults with moderate to severe Crohn's disease after a biologic has not worked, stopped working or was not tolerated, or when anti-TNF medicines are unsuitable.
Topics
Medicines
Biologics and newer medicines
Jargon explained
JAK inhibitor
small molecule
TNF-alpha inhibitor
Crohn's & Colitis UK
Guide
For patients
A guide to upadacitinib (Rinvoq), a tablet that belongs to the JAK inhibitor group of targeted medicines. It explains how blocking JAK proteins calms the immune response, what trials showed, and the side effects and safety checks involved.
Topics
Medicines
Biologics and newer medicines
Jargon explained
JAK inhibitor
Janus kinase
targeted medicine
small molecule
Crohn's & Colitis UK
Guide
Jul 2023
For patients
An overview of biologics and other targeted medicines for Crohn's and Colitis, with a table of each medicine, its brand names and how it works. It explains that biologics are lab-made antibodies given by drip or injection, and covers biosimilars, anti-TNFs, interleukin inhibitors and JAK inhibitors.
Topics
Biologics and newer medicines
Medicines
Jargon explained
biologic
biosimilar
anti-TNF
IL-23 inhibitor
JAK inhibitor
advanced therapy
Crohn's & Colitis UK
Web page
Sep 2026
For patients
A summary of the 2026 flu, COVID-19 booster and RSV vaccines across the four UK nations. Having Crohn's alone does not make you eligible, but taking immune-lowering medicines such as azathioprine, methotrexate, biologics, targeted tablets or higher-dose steroids may. Speak to your healthcare team if you are unsure.
Topics
Vaccinations and infections
Jargon explained
flu vaccine
COVID-19 booster
RSV vaccine
immunosuppressant
NICE
Guideline
Jul 2017
For professionals
NICE's appraisal recommending ustekinumab (Stelara) for adults with moderate to severe Crohn's disease when standard treatment or an anti-TNF medicine has not worked, stopped working or cannot be used. It says the choice between biologics should be made with the patient, using the cheapest suitable option.
Topics
Biologics and newer medicines
Medicines
Jargon explained
interleukin inhibitor
TNF-alpha inhibitor
biological therapy